Twentyeight Seven Therapeutics
HealthcareBiotech & Pharma
HQ: Watertown, United States
Investors: 1
A biotechnology company focused on the modulation of RNA to treat cancer and other human diseases by targeting RNA-modulating proteins (RMPs).
Investors (1)
| Fund | Status | Entry Date | Stage | Source |
|---|---|---|---|---|
| Sofinnova Partners | Exited | - | - | Website |
Get these signals delivered weekly
Deals, exits, fundraises, and key hires from funds active in Italy — straight to your inbox.
Get Signals